Key result
FVB/N mice fed a 32-week western diet best replicate human NASH and metabolic comorbidities.
Why the study?
There is a lack of adequate mouse models of NASH that also show metabolic comorbidities commonly observed in NASH patients, hindering pre-clinical to clinical translation of therapies.
Population
Eight common inbred mouse strains fed western-style diet
Comparison
Comparison among eight mouse strains under western-style diet
Design
Pre-clinical comparative study
Authors
Loading...
Early-phase signals in NASH warrant larger trials; leaves open whether histologic benefits will translate to approved therapy.
The FVB/N mouse strain fed a western-style diet for 8 months is an optimal preclinical model for studying MAFLD and NASH with associated metabolic comorbidities.
Karimkhanloo et al. (2023) studied Metabolic associated fatty liver disease (MAFLD) and Non-alcoholic steatohepatitis (NASH). Western-style diet enriched in fat, sucrose, fructose and cholesterol vs. Rodent chow diet was evaluated on Prevalence of NASH, liver fibrosis, and metabolic comorbidities. The FVB/N mouse strain fed a western-style diet for 32 weeks most faithfully recapitulates human NASH pathophysiology and predominant metabolic comorbidities, including obesity and insulin resistance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: